Greetings to all my article readers!
The project itself is personally interesting to me and now I will try to talk about it.
I will not draw with introductions and get to the bottom of the matter right away.
The field of health care is changing. Two revolutionary-genomic technologies,
and blockchain, ready to significantly improve human health and well-being.
Genome treatment can improve the understanding and treatment of more than 7,000 rare diseases, along with cancer,complex and long-term diseases such as disease and cardiovascular and neurodegenerative infections.
In addition, blockchain technology alters the future of world health and economics: it is ready to deliver the greatest transformation in innovation since the advent of the Internet and web 2.0.
Shivom is the next evolutionary step in this development, incorporating this technology project creating a revolutionary medical genomic ecosystem that will open up the possibility of health care for all.
Shivom offers the first comprehensive solution of genome data for patients and donors, where everyone can have the genome and store it safely.
The ecosystem will provide open web markets for pharmaceutical suppliers, research organizations, governments, patient support groups, and insurance companies to add their applications and services, along with personalized genome and drug data analytics.
Shivom's global platform works based on principles of cooperation, openness, honesty, security, and informed choice.
The cost of DNA sequencing has decreased significantly. It is assumed that by the end of the decade it will be possible to produce an entire human gene with less than or more than $ 100.
This will make personal health ideas accessible to almost everyone around the world. More recently, in January 2017, leading illumina sequencing provider introduced a new sequencer, NovaSeq, eventually the company report will provide the entire genome for less than $ 100.
This is a new dawn for access to personalized and accurate medicine that has a global scale.
Genomic sequencing has many advantages:
- Determination of the best treatment for patients with certain conditions
Prevention of disease in healthy people
Predicting disease risk
Diagnosis of the disease
- Treatment, including the most effective drug selection and dose
- Estimated disease
We envision a future in which genome data becomes widespread, with insights to improve health reliability and accessibility for all.
Shivom is a pioneer of the omics ecosystem to make this vision a reality, the project offers its first rapidly growing investment offer in the personalized pharmaceuticals market, based on modern blockchain technology.
Shivom researchers will use the data, as well as tools and techniques, particularly machine learning methods, underlying artificial intelligence, which promise to improve health care systems and services worldwide.
Blockchain technology is our technology partner because it is able to handle trust issues, including patient compliance, data ownership, data integrity and identification.
Blockchain can also manage complex data rights and will allow access through smart contracts.
Identify new drug target:
Blockchain technology helps users transmit genome data or quantitative lifestyles, as well as information to other interested parties.
At the same time, information such as substance abuse data enables stakeholders to stimulate changes in the client's lifestyle.
For example, insurance companies can offer clients to sequence their genomes. Using intelligent contracts based on permission, access to genome information will be penalized by blockbusters with potential stimulus from users or donors, all information about him remains secure and anonymous.
The project plans to build a global network of genetic counselors that can also form a telemedicine ecosystem (if people in rural areas do not have direct access to health care). Ultimately, most people will undergo genetic testing and counseling and not only with a clearly increased genetic risk.
Our consultants and laboratories will also serve as information centers, as genome data becomes more common in clinics, it is critical that clinical, scientific and physician workers use automated and integrated tools that do not use pre-modern methods using the Shivom platform.
Thanks for taking the time to read my article and see you again!....
